(4E,7E)-trideca-1,4,7-triene

Details

Top
Internal ID 2fe296c9-da53-4ef3-8ab6-82bcd7bc5513
Taxonomy Hydrocarbons > Unsaturated hydrocarbons > Olefins > Acyclic olefins > Alkatrienes
IUPAC Name (4E,7E)-trideca-1,4,7-triene
SMILES (Canonical) CCCCCC=CCC=CCC=C
SMILES (Isomeric) CCCCC/C=C/C/C=C/CC=C
InChI InChI=1S/C13H22/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3,7,9,12-13H,1,4-6,8,10-11H2,2H3/b9-7+,13-12+
InChI Key BCEQUJFGDSSSKU-JCSVKFCRSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C13H22
Molecular Weight 178.31 g/mol
Exact Mass 178.172150702 g/mol
Topological Polar Surface Area (TPSA) 0.00 Ų
XlogP 5.40
Atomic LogP (AlogP) 4.65
H-Bond Acceptor 0
H-Bond Donor 0
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4E,7E)-trideca-1,4,7-triene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9906 99.06%
Caco-2 + 0.9683 96.83%
Blood Brain Barrier + 0.9750 97.50%
Human oral bioavailability + 0.6857 68.57%
Subcellular localzation Lysosomes 0.4578 45.78%
OATP2B1 inhibitior - 0.8598 85.98%
OATP1B1 inhibitior - 0.3423 34.23%
OATP1B3 inhibitior + 0.9239 92.39%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.8250 82.50%
BSEP inhibitior - 0.8128 81.28%
P-glycoprotein inhibitior - 0.9671 96.71%
P-glycoprotein substrate - 0.9364 93.64%
CYP3A4 substrate - 0.6388 63.88%
CYP2C9 substrate - 0.8202 82.02%
CYP2D6 substrate - 0.7454 74.54%
CYP3A4 inhibition - 0.9832 98.32%
CYP2C9 inhibition - 0.9157 91.57%
CYP2C19 inhibition - 0.9190 91.90%
CYP2D6 inhibition - 0.9426 94.26%
CYP1A2 inhibition + 0.5418 54.18%
CYP2C8 inhibition - 0.8744 87.44%
CYP inhibitory promiscuity - 0.6838 68.38%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.5800 58.00%
Carcinogenicity (trinary) Non-required 0.5494 54.94%
Eye corrosion + 0.9841 98.41%
Eye irritation + 0.9675 96.75%
Skin irritation + 0.8622 86.22%
Skin corrosion - 0.9742 97.42%
Ames mutagenesis - 0.7800 78.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5244 52.44%
Micronuclear - 1.0000 100.00%
Hepatotoxicity - 0.5176 51.76%
skin sensitisation + 0.9605 96.05%
Respiratory toxicity - 0.8778 87.78%
Reproductive toxicity - 1.0000 100.00%
Mitochondrial toxicity - 1.0000 100.00%
Nephrotoxicity + 0.5069 50.69%
Acute Oral Toxicity (c) III 0.6572 65.72%
Estrogen receptor binding - 0.8644 86.44%
Androgen receptor binding - 0.8432 84.32%
Thyroid receptor binding + 0.5990 59.90%
Glucocorticoid receptor binding - 0.6811 68.11%
Aromatase binding - 0.7971 79.71%
PPAR gamma + 0.6697 66.97%
Honey bee toxicity - 0.9747 97.47%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity + 0.6800 68.00%
Fish aquatic toxicity + 0.9955 99.55%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 93.57% 98.95%
CHEMBL4769 O95749 Geranylgeranyl pyrophosphate synthetase 92.03% 92.08%
CHEMBL239 Q07869 Peroxisome proliferator-activated receptor alpha 91.31% 90.75%
CHEMBL3060 Q9Y345 Glycine transporter 2 91.18% 99.17%
CHEMBL2265 P23141 Acyl coenzyme A:cholesterol acyltransferase 89.22% 85.94%
CHEMBL230 P35354 Cyclooxygenase-2 84.42% 89.63%
CHEMBL5043 Q6P179 Endoplasmic reticulum aminopeptidase 2 84.20% 91.81%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 83.86% 96.09%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 82.78% 92.86%
CHEMBL221 P23219 Cyclooxygenase-1 82.59% 90.17%
CHEMBL2885 P07451 Carbonic anhydrase III 82.14% 87.45%
CHEMBL1781 P11387 DNA topoisomerase I 81.45% 97.00%
CHEMBL1907 P15144 Aminopeptidase N 81.27% 93.31%

Cross-Links

Top
PubChem 5322027
NPASS NPC68153
LOTUS LTS0052379
wikiData Q104923263